RA-UIP has a poor prognosis, and how to reverse or stabilize the lesions remains challenging. Based on researches finding that tofacitinib and IGU might be effective in pulmonary fibrosis, we present 3 cases that treated with the combined strategy with significant improvement of DAS28-CRP score and reversals in HRCT.